Anika Therapeutics Inc - Common Stock (ANIK)

CUSIP: 035255108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
13,404,566
Total 13F shares
12,529,691
Share change
-551,709
Total reported value
$206,235,517
Put/Call ratio
106%
Price per share
$16.46
Number of holders
108
Value change
-$14,093,626
Number of buys
49
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Trigran Investments, Inc.
13F
Company
16%
2,124,460
$52,474,161 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
13%
1,764,607
$43,585,794 30 Sep 2024
13F
Caligan Partners LP
13F
Company
11%
1,435,130
$35,447,711 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
6%
798,643
$19,726,482 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F 13D/G
Company
4.5%
from 13D/G
707,366
$17,471,831 30 Sep 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.3%
574,229
$14,183,456 30 Sep 2024
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
3.8%
503,838
$12,444,799 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
3.4%
452,977
$11,188,531 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3.3%
448,784
$11,082,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
324,964
$8,028,969 30 Sep 2024
13F
STATE STREET CORP
13F
Company
2.3%
305,225
$7,539,058 30 Sep 2024
13F
Alta Fundamental Advisers LLC
13F
Company
2.2%
296,082
$7,313,225 30 Sep 2024
13F
CAPITAL MANAGEMENT CORP /VA
13F
Company
2.2%
290,350
$7,171,645 30 Sep 2024
13F
Meros Investment Management, LP
13F
Company
1.8%
237,295
$5,861,187 30 Sep 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.4%
189,308
$4,675,908 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
1.1%
154,061
$3,805,307 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.1%
149,956
$3,703,913 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
1%
133,410
$3,380,609 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.92%
123,310
$3,045,757 30 Sep 2024
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.81%
108,799
$2,687,335 30 Sep 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.81%
108,793
$2,687,187 30 Sep 2024
13F
Riverwater Partners LLC
13F
Company
0.76%
101,996
$2,551,940 30 Sep 2024
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.73%
97,999
$2,420,575 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.66%
88,727
$2,191,557 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.64%
86,304
$2,131,709 30 Sep 2024
13F
Michael L. Levitz
3/4/5
EVP, CFO, Treasurer
mixed-class rows
119,966
mixed-class rows
$1,761,044 15 Mar 2024
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.52%
70,119
$1,731,939 30 Sep 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.51%
67,802
$1,674,709 30 Sep 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.43%
57,606
$1,422,868 30 Sep 2024
13F
DIKER MANAGEMENT LLC
13F
Company
0.42%
56,839
$1,403,923 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.38%
50,745
$1,253,402 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.37%
49,026
$1,210,000 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.35%
46,564
$1,150,131 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.31%
42,070
$1,039,129 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.31%
41,818
$1,032,898 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.31%
41,315
$1,020,480 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
39,509
$975,872 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.29%
39,083
$965,350 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.29%
38,378
$947,937 30 Sep 2024
13F
Fisher Asset Management, LLC
13F
Company
0.26%
34,494
$852,001 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.26%
34,460
$851,162 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.24%
32,664
$806,801 30 Sep 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.23%
31,475
$777,000 30 Sep 2024
13F
Susquehanna Portfolio Strategies, LLC
13F
Company
0.23%
30,976
$765,107 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.23%
30,692
$758,093 30 Sep 2024
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.22%
29,342
$724,747 30 Sep 2024
13F
IRONWOOD INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
29,058
$717,733 30 Sep 2024
13F
PRIO WEALTH LIMITED PARTNERSHIP
13F
Company
0.21%
28,800
$711,360 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.21%
28,451
$702,740 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.2%
27,338
$675,249 30 Sep 2024
13F

Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q4 2024

As of 31 Dec 2024, Anika Therapeutics Inc - Common Stock (ANIK) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,529,691 shares. The largest 10 holders included Trigran Investments, Inc., BlackRock, Inc., Caligan Partners LP, VANGUARD GROUP INC, Alta Fundamental Advisers LLC, DIMENSIONAL FUND ADVISORS LP, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, and CAPITAL MANAGEMENT CORP /VA. This page lists 108 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
121
Q4 2024 holders
108
Holder diff
-13
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .